Simulations Plus Faces Securities Investigations
Analysis based on 28 articles · First reported Jun 01, 2026 · Last updated Jun 10, 2026
The market has reacted negatively to the developments at Simulations Plus>>>, with its stock price declining significantly after the revised revenue guidance, impairment charge, and auditor dismissal. This event highlights potential risks for investors in the pharmaceutical, biotechnology, and software industries, particularly concerning financial reporting and internal controls.
Shareholder rights law firms Robbins LLP>>> and Johnson Fistel>>> are investigating Simulations Plus>>> for potential securities law violations and breaches of fiduciary duties by its officers and directors. This follows Simulations Plus>>>'s announcement of reduced full-year fiscal 2025 revenue guidance, a significant net loss of $67.3 million including a $77.2 million non-cash impairment charge, and the dismissal of its auditor, Grant Thornton Bharat>>>. Grant Thornton Bharat>>> subsequently filed a letter with the SEC, disagreeing with Simulations Plus>>>'s characterization of the dismissal and stating that certain matters related to segment reporting and internal controls were not resolved to its satisfaction. These events have led to substantial declines in Simulations Plus>>>'s stock price.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard